EUVIMEDEUVIMED entdecken
Open Access

Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma

Yanfei Sun, Guangjing Mu, Xuehai Zhang, Yibo Wu, Shuai Wang, Xu Wang, Zhiwei Xue, Chuanwei Wang, Jilong Liu, Wenbo Li, Lin Zhang, Yunyun Guo und 9 weitere

Neuro-Oncology · 05.04.2024 · 26 (4) · 653-669

DOI: 10.1093/neuonc/noad232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 09.12.2023. Verfasst von Yanfei Sun und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine, Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, Ch…. Hauptthemen laut MEDLINE: Aminopyridines, Glioblastoma, Hydrazones, Lyases. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of China, Department of Science and Technology of Shandong Province, Research Project of Jinan Microecological Biomedicine Shandong Laboratory.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Altered branched-chain amino acid (BCAA) metabolism modulates epigenetic modification, such as H3K27ac in cancer, thus providing a link between metabolic reprogramming and epigenetic change, which are prominent hallmarks of glioblastoma multiforme (GBM). Here, we identified mitochondrial 3-hydroxymethyl-3-methylglutaryl-CoA lyase (HMGCL), an enzyme involved in leucine degradation, promoting GBM progression and glioma stem cell (GSC) maintenance.

Methods

In silico analysis was performed to identify specific molecules involved in multiple processes. Glioblastoma multiforme cells were infected with knockdown/overexpression lentiviral constructs of HMGCL to assess malignant performance in vitro and in an orthotopic xenograft model. RNA sequencing was used to identify potential downstream molecular targets.

Results

HMGCL, as a gene, increased in GBM and was associated with poor survival in patients. Knockdown of HMGCL suppressed proliferation and invasion in vitro and in vivo. Acetyl-CoA was decreased with HMGCL knockdown, which led to reduced NFAT1 nuclear accumulation and H3K27ac level. RNA sequencing-based transcriptomic profiling revealed FOXM1 as a candidate downstream target, and HMGCL-mediated H3K27ac modification in the FOXM1 promoter induced transcription of the gene. Loss of FOXM1 protein with HMGCL knockdown led to decreased nuclear translocation and thus activity of β-catenin, a known oncogene. Finally, JIB-04, a small molecule confirmed to bind to HMGCL, suppressed GBM tumorigenesis in vitro and in vivo.

Conclusions

Changes in acetyl-CoA levels induced by HMGCL altered H3K27ac modification, which triggers transcription of FOXM1 and β-catenin nuclear translocation. Targeting HMGCL by JIB-04 inhibited tumor growth, indicating that mediators of BCAA metabolism may serve as molecular targets for effective GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AminopyridinesGlioblastomaHydrazonesLyasesHumansAcetyl Coenzyme AAcetylationbeta CateninCell Line, TumorCell ProliferationForkhead Box Protein M1Gene Expression Regulation, NeoplasticHistonesOxo-Acid-Lyases

Stichwörter der Autor:innen

FOXM1HMGCLglioblastomahistone acetylationmetabolic regulation

Substanzen

Acetyl Coenzyme AAminopyridinesbeta CateninForkhead Box Protein M1HistonesHydrazonesLyasesFOXM1 protein, humanJIB-04CTNNB1 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine, Institute of Brain and Brain-Inspired Science, Shandong University, Jinan, China.
  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
  • Shandong Key Laboratory of Brain Function Remodeling, Jinan, China.
  • Medical Integration and Practice Center, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • Department of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA.
  • Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Bin Huang

Förderung

  • Natural Science Foundation of China
  • Department of Science and Technology of Shandong Province
  • Research Project of Jinan Microecological Biomedicine Shandong Laboratory
  • Clinical Research Center of Shandong University
  • Shandong Excellent Young Scientists Fund Program
  • Special Foundation for Taishan Young Scholars
  • Qilu Young Scholar Program of Shandong University

Zitieren

APA

Sun, Y., Mu, G., Zhang, X., Wu, Y., Wang, S., Wang, X., Xue, Z., Wang, C., Liu, J., Li, W., Zhang, L., Guo, Y., Zhao, F., Liu, X., Xue, Z., Zhang, Y., Ni, S., Wang, J., Li, X., …, & Huang, B. (2024). Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma. Neuro-Oncology, 26(4), 653-669. https://doi.org/10.1093/neuonc/noad232

Vancouver

Sun Y, Mu G, Zhang X, Wu Y, Wang S, Wang X, et al. Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma. Neuro-Oncology. 2024;26(4):653-669. doi:10.1093/neuonc/noad232

BibTeX
@article{Sun2024,
  author = {Sun, Yanfei and Mu, Guangjing and Zhang, Xuehai and Wu, Yibo and Wang, Shuai and Wang, Xu and Xue, Zhiwei and Wang, Chuanwei and Liu, Jilong and Li, Wenbo and Zhang, Lin and Guo, Yunyun and Zhao, Feihu and Liu, Xuemeng and Xue, Zhiyi and Zhang, Yan and Ni, Shilei and Wang, Jian and Li, Xingang and Han, Mingzhi and Huang, Bin},
  title = {Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma},
  journal = {Neuro-Oncology},
  year = {2024},
  volume = {26},
  number = {4},
  pages = {653--669},
  doi = {10.1093/neuonc/noad232}
}
Kostenlos starten →